References
- Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878–1886.
- Swerdlow AJ, Higgins CD, Smith P, et al Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007;99:206–214.
- Tsang RW, Hodgson DC, Crump M. Hodgkin's lymphoma. Curr Probl Cancer 2006;30:107–158.
- Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953–964.
- Hoppe BS, Flampouri S, Li Z, Mendenhall NP. Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. Leuk Lymphoma 2010;51. 1559–1562.
- Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413–426.
- Chera BS, Rodriguez C, Morris CG, et al Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009;75:1173–1180.
- Olsen DR, Bruland OS, Frykholm G, et al Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 2007;83:123–132.